期刊文献+

Cyclin D1在乳腺浸润性小叶癌的表达及其意义 被引量:3

Expression of Cyclin D1 in Invasive Lobular Carcinoma of the Breast and Its Significance
下载PDF
导出
摘要 目的探讨Cyclin D1在乳腺浸润性小叶癌中的表达及其意义。方法采用免疫组化染色方法对75例具有经典型乳腺浸润性小叶癌结构的标本进行Cyclin D1免疫组化检测。结果 Cyclin D1阳性表达率为93.33%(70/75),其中41例(54.67%)呈弥漫强阳性表达(3+,6~7分),21例(28%)呈中阳性表达(2+,4~5分),8例(10.67%)呈弱阳性表达(1+,2~3分);仅有5例(6.67%)呈阴性表达(0~1分)。Cyclin D1的阳性表达在患者年龄是否≥50岁、肿瘤最大径是否≥2cm、淋巴结是否有转移、是否累及乳头间质及其下大导管、雌孕激素受体有无及P53是否突变等因素的分组中无统计学差异(P>0.05);而CyclinD1阳性表达程度与淋巴结是否有转移具有一定的负相关性(P<0.05)。结论 Cyclin D1在乳腺浸润性小叶癌中呈过表达状态,该蛋白过表达提示其在基因水平上可能出现了某种程度的异常,这一假设尚需进一步行基因检测加以证实。 Objective To investigate the expression and its significance of Cyclin D1 in invasive lobular carcinoma (ILC) of the breast. Methods The specimens from 75 cases of ILC were detected using immuno- histochemieal method. Results Of these 75 cases, Cyclin D1 was positive on the nucleus in 70 cases (93.33%), among which 41 (54.67%) showed strong diffuse staining (3 ~, 6-7 points), and 21 (28%) were moderately positive (2 +, 4-5 points), and 8 ( 10.67% ) were weak positive ( 1 +, 2-3 points). Only 5 (6. 67% ) cases showed negative results (0-1 points). The positive expression of Cyclin D1 showed no sig- nificant differences among patients in terms of age ( 〉 50 years) , maximum tumor diameter ( 〉 2cm) , lymph node metastasis, involvement of papillary interstitial tissue and the large duct beneath it, existence of estrogen and progesterone receptors, and the possible mutation of P53. However, an inverse correlation was found be- tween the degrees of the positive staining of Cyelin D1 and the lymph node metastasis ( P 〈 0. 05 ). Conclusion Cyclin D1 is overexpressed in ILC, suggesting that there may be certain genetic abnormalities.
出处 《协和医学杂志》 2012年第1期8-12,共5页 Medical Journal of Peking Union Medical College Hospital
关键词 CYCLIN D1 细胞周期蛋白 乳腺癌 浸润性小叶癌 Cyclin D1 cyclins breast cancer invasive lobular carcinoma
  • 相关文献

参考文献15

  • 1Tavassoli FA,Devilee P. World Health Organization classification of tumors.pathology and genetics of tumors of the breast and female genital organs[M].Lyon:iarc Press,2003.
  • 2Li CI,Anderson BO,Porter P. Changing incidence rate of invasive lobular breast carcinoma among older women[J].Cancer,2000.2561-2569.
  • 3Reeves GK,Beral V,Green J. Hormonal therapy for menopause and breast-cancer risk by histological type:a cohort study and meta-analysis[J].Lancet Oncology,2006,(11):910-918.doi:10.1016/S1470-2045(06)70911-1.
  • 4Biglia N,Sgro L,Defabiani E. The influence of hormone replacement therapy on the pathology of breast cancer[J].European Journal of Surgical Oncology,2005,(5):467-472.doi:10.1016/j.ejso.2005.02.005.
  • 5Newcomb PA,Titus-Ernstoff L,Egan KM. Postmenopausal estrogen and progestin use in relation to breast cancer risk[J].Cancer Epidemiology Biomarkers and Prevention,2002.593-600.
  • 6Motokura T,Bloom T,Kim HG. A novel cyclin encoded by a bcl1-linked candidate oncogene[J].Nature,1991.462-463.doi:10.1038/350512a0.
  • 7Dreyling M,Kluin-Nelemans HC,Beà S. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma:report of the 10th annual conference of the European Mantle Cell Lymphoma Network[J].Leukemia and Lymphoma,2011.2226-2236.
  • 8Kosacka M,Piesiak P,Kowal A. Galectin-3 and cyclin D1 expression in non-small cell lung cancer[J].Journal of Experimental & Clinical Cancer Research,2011.101.doi:10.1186/1756-9966-30-101.
  • 9Shenoy AM. Cyclin D1 over expression as a prognostic factor in patients with tobacco-relatedintraoral squamous cell carcinoma[J].Indian Journal of Medical Research,2011.364-365.
  • 10Oba J,Nakahara T,Abe T. Expression of c-Kit,pERK and cyclin D1 in malignant melanoma:an immunohistochemical study and analysis of prognostic value[J].Journal of Dermatological Science,2011.116-123.doi:10.1016/j.jdermsci.2011.02.011.

同被引文献32

  • 1杜芸,王小玲,吴国祥,王永军,杨会钗,左连富.流式细胞术对食管癌组织中四种细胞周期调控蛋白的定量检测及意义[J].中华肿瘤杂志,2004,26(10):612-614. 被引量:8
  • 2高红,张志波,尚海.p57^(Kip2)和p27^(Kip1)基因mRNA在胃癌组织中的表达及意义[J].中国医科大学学报,2004,33(6):525-526. 被引量:4
  • 3陈晓曦,陈吉彩,程骏,陈哲京,朱冠保,姚建高.CyclinD1在乳腺癌中的表达及意义[J].山东医药,2006,46(34):64-65. 被引量:1
  • 4Scully C, Field J K, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 3 : Clinieo-pathologieal ap- plications[J]. Oral Oncol, 2000, 36(5) :404 - 13.
  • 5Bahar I, Chennubhotla C, Tobi D. Intrinsic dynamics of enzymes in the unbound state and relation to allosterie regulation[ J]. Cur- ropin Struet Bio1,2007,17 (6) : 633 -40.
  • 6Israels E D, Israels L G. The cell cycle[J]. Stem Cell,2001,19 (1) :88 -91.
  • 7Sears R C, Nevins J R. Signaling networks that link cell prolifera- tion and cell fate [ J ]. J Biol Chem,2002,277 (14) : 11617 - 20.
  • 8Farley J, Smith L M, Darcy K M, et al. Cyclin E expression is a significant predictor of survival in advanced, suboptimally de- bulked ovarian epithelial cancer: a gynecologic oncology group study [ J]. Cancer Res,2003,63 (6) : 1235 - 41.
  • 9Ito Y, Yoshida H, Nakano K, et al. Expression of p57klp2 protein in normal and neoplastic thyroid tissues[ J]. Int J Mol Med,2002, 9(4) :373 -6.
  • 10Ito Y, Takeda T, Sasaki Y, et al. Expression of p57kip2 protein in extrahepatie bile duct carcinoma and intrahepatic cholangiocellular carcinoma[ J ]. Liver ,2002, 22 (2) : 145 - 9.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部